epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Amethia
    levonorgestrel/ ethinyl estradiol
  • remove Amjevita (adalimumab-atto)
    adalimumab
  • remove mifepristone
    generic

multicheck MultiCheck Results - 2 Interactions

Smiley face Smiley face

Avoid/Use Alternative

Smiley face Smiley face Amethia (levonorgestrel/ ethinyl estradiol) + mifepristone (generic)

Avoid/Use Alternative


ethinyl estradiol (contraceptive) + mifepristone

use alternative non-hormonal contraception during and x1mo after daily mifepristone use: combo may incr. ethinyl estradiol levels, risk of thromboembolism, other adverse effects (hepatic metabolism inhibited)

levonorgestrel (contraceptive) + mifepristone

use alternative non-hormonal contraception during and x1mo after daily mifepristone use: combo may decr. hormonal contraceptive efficacy (antagonistic effects)

Additional Considerations

Smiley face Smiley face adalimumab in Amjevita (adalimumab-atto)

caution advised with narrow therapeutic index drugs; chronic inflammatory conditions may alter metabolic enzyme formation; tx with immune modulators may reverse this effect, resulting in altered levels of concomitant drugs

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information